Methylation Pattern Mediated by m6A Regulator and Tumor Microenvironment Invasion in Lung Adenocarcinoma

Abstract

Background. Recent research has established the existence of epigenetic modulation of the immune response. The possible involvement of RNA-n6-methyladenosine (m6A) alteration in tumor microenvironment (TME) cell invasion, on the other hand, is unknown. Methods. Based on 23 m6A regulators, we examined the alteration patterns of m6A in 629 LUAD tissues and comprehensively connected these modification patterns with TME cell invasion characteristics. The m6A score was calculated, and the m6A modification pattern of a single tumor was quantified using principal component analysis. Then, we further verified the expression of m6A related enzymes and the role hub gene (NOL10) closely related to survival in lung cancer cell lines. Results. Three separate m6A alteration modes have been discovered. TME cell invasion characteristics in the three modes were very similar to the three immunological phenotypes of tumors: immunological rejection, immunological inflammation, and immunological desert. We show that assessing the m6A modification pattern in a single tumor may help predict tumor inflammatory stage, subtype, TME interstitial activity, and prognosis. TME phenotypic inflammation is indicated by a high m6A score, which is characterized by elevated mutation load and immunological activation. The low m6A subtype showed matrix activation and ineffective immune infiltration, indicating that the TME phenotype of noninflammation and immunological rejection had a poor survival probability. Increased neoantigen burden was also linked to a high m6A score. Patients with a higher m6A score saw substantial therapeutic and clinical improvements. And reducing hub gene NOL10 expression substantially inhibited lung cancer cell growth and migration. Conclusions. This research shows that m6A alteration is critical in the creation of TME variety and complexity. The analysis of a single tumor’s m6A alteration pattern will aid in improving our knowledge of TME invasion features and guiding more effective immunotherapy tactics.

Delicaflavone Represses Lung Cancer Growth by Activating Antitumor Immune Response through N6-Methyladenosine Transferases and Oxidative Stress

“…Studies have showed that phytochemicals from natural products induce the accumulation of ROS by damaging DNA biomolecules and triggering cell death-related signaling pathways, including m6A modification [ 34 ]. m6A alteration is critical in the creation of tumor immune microenvironment variety and complexity in lung cancer [ 35 ]. Reactive oxygen species (ROS) can damage lipids, nucleic acids, and proteins, thereby altering their functions.…”

Development and validation of a robust necroptosis related classifier for colon adenocarcinoma

“…Many studies have shown that bioinformatics has amazing prospects in dealing with genomic variation, TME, and precision therapy (Jiang et al, 2020;Wang et al, 2021;Jiang et al, 2022;Yu et al, 2022). As previous results strongly suggested higher sensitivity to treatment among patients in the low-risk group, we finally analyzed the sensitivity of COAD patients in both groups towards chemotherapy and immunotherapy.…”

Significance of m6A regulatory factor in gene expression and immune function of osteoarthritis

“…The following are the criteria we use to choose datasets: first, the sample size must be larger than 100; second, the data set must include both a treatment and a healthy control; third, in both the patient and control groups, there must be at least 10 cases in each. These regulators consisted of nine writers (METTL3, METTL14, METTL16, WTAP, VIRMA, RBM15, RBM15B, CBLL1, and ZC3H13), two erasers (FTO and ALKBH5), and 15 readers (YTHDC1, YTHDC2, YTHDF1, YTHDF2, YTHDF3, HNRNPC, FMR1, LRPPRC, HNRNPA2B1, IGFBP1, IGFBP2, IGFBP3, RBMX, ELAVL1, and IGF2BP1) ( Dai et al, 2021 ; Jiang et al, 2022 ).…”